,Name: Class: Date:u
Chapteru1uConsumeruSafetyuanduDruguRegulations
1. Auclientucallsuheruprimaryucareuproviderurequestinguauprescriptionuforuanuantidepressantumedication.uSheutellsut
heunurseuthatusheuisuseverelyudepresseduanduwouldulikeutheuprescriptionucalleduinutouherulocalupharmacy.uHowusho
uldutheunurseurespond?
a. Theunurseuencouragesutheuclientutouseeuaupsychiatricuprofessionaluforuanuevaluationutouobtainutheup
rescription.
b. Theunurseutellsutheuclientutouaskutheupharmacistutourecommenduanuover-the-counteruantidepressant.
c. Theunurseucanuofferutouwriteutheuclientuauprescriptionuifuitu isuaurefill.
d. Theunurseuoffersutougiveutheuclientuaufewusamplesutouuseuuntiluherunextuappointment.
ANSWER: a
FEEDBACK:
a.uTheuclientushouldubeuencouragedutouseekuaupsychiatricuprofessionaluevaluationutouo
btainutheuprescription.
b. Antidepressantsuareunotusolduasuover-the-
counterumedications;uauprescriptionuisurequired.uTryuagain.
c. Theunurseucannotuwriteuauprescriptionuwithoutuevaluatingutheuclient.uTryuagain.
d. Samplesuareunotugivenuoututouauclientuwhouhasunotubeenuevaluatedubyuaupractitioner.uTryu
again.
POINTS: 1
QUESTIONuTYPE:u MultipleuChoice
HASuVARIABLES:u False
DATEuCREATED: 11/26/2017u8:16uPM
DATEuMODIFIED:u 11/26/2017u8:32uPM
2. Auclientuvisitsuheruhealthucareuprovideruforuheruannualuphysical.uSheuquestionsutheunurseuregardingutheuuseuofua
nuherbalusupplementuthatusheusawuadvertiseduonutelevisionuforuweightuloss.uWhatuinformationucanutheunurseushar
euwithuheruclient?
a. TheuproductionuofuherbalumedicinesuisunoturegulatedubyutheuFDA.
b. UnderutheuDietaryuSupplementu HealthuanduEducationuActuofu1994u(DSHEA),utheuFDAuisuresponsibleuf
oruensuringuthatuaudietaryusupplementu isusafeubeforeu ituisumarketed.
c. HerbalumedicinesuareutestedubyutheuFDAutoudetermineuifutheyuhaveuinteractionsuwithuprescribedu
medications.
d. Herbalumedicines,uwhileunotuapprovedubyutheuFDA,uareuconsidereduharmless.
ANSWER: a
FEEDBACK: a.uTheuproductionuofuherbalumedicinesuisunoturegulatedubyutheuFDA.
b. UnderutheuDietaryuSupplementuHealthuanduEducationuActuofu1994u(DSHEA),utheudietaryu
manufactureruisuresponsibleuforuensuringuthatuaudietaryusupplementuisusafeubeforeuituisu
marketed.uTryuagain.
c. TheuFDAudoesunotutestusupplements.uTryuagain.
d. Thereuareudocumenteduinteractionsuwithuspecificuherbalusupplementsuanduprescribedu
medications.uTryuagain.
POINTS: 1
QUESTIONuTYPE:u MultipleuChoice
HASuVARIABLES:u False
DATEuCREATED: 11/26/2017u8:22uPM
DATEuMODIFIED:u 11/26/2017u8:32uPM
Pageu1
,Name: Class: Date:u
Chapteru1uConsumeruSafetyuanduDruguRegulations
3. Uponuleavingutheuexamuroom,uauclientutellsutheunurseuthatusheuisuconfuseduregardinguheruprescription.uSheuasksuth
eunurseuifuaucheaper,ugenericudruguwillubeuweakeruthanuherucurrentuprescription.uHowushouldutheunurseurespond?
a. Drugustandardsuassureuconsumersuthatutheusameudrugumustubeuofuuniformustrength,uquality,uandupurity.
b. Theuprescribedumedicationuisuofubetteruqualityubutuwillucostumore.
c. Theuinsuranceucompaniesumandateuthereuareudifferentustrengthsubetweenugenericuandubrandunameup
rescriptions.
d. Everyudruguhasuaudifferentuchemicalucompositionuthatucannotubeuduplicated.
ANSWER: a
FEEDBACK:
a.uDrugustandardsuassureuconsumersuthatutheusameudrugumustubeuofuuniformustre
ngth,uquality,uandupurity.
b. Genericuandutradeudrugsuareutheusameumedication.uGenericuisutheunameuthatuisuassignedu
touaunewudrug.uTheutradeunameuisutheunameutheupharmaceuticalucompanyuassignsutouthatu
drugutouhaveuexclusiveurightsutoumarketuit.uTryuagain.
c. Insuranceucompaniesuhaveunoucontroluoverutheuproductionuofumedication.uTryuagain.
d. Theulawsuregulatingudrugsustateuthatuconsumersucanubeuassureduthatuallupreparationsu
withutheusameunameuhaveutheusameuuniformu strength,uquality,uandupurity.uTryuagain.
POINTS: 1
QUESTIONuTYPE:u MultipleuChoice
HASuVARIABLES:u False
DATEuCREATED: 11/26/2017u8:23uPM
DATEuMODIFIED:u 11/26/2017u8:31uPM
4. TheuFDA,uunderutheudirectionuofutheuDepartmentuofuHealthuanduHumanuServices,u mandatesuwhichuofutheuf
ollowing?
a. Prescriptionuandunonprescriptionudrugsumustubeushownutoubeueffectiveuasuwelluasusafe.
b. Allulabelsumustuincludeuaulistinguofuactiveuingredients;usomeulabelsurequireuaulistinguofuinactiveuin
gredientsuasuwell.
c. AllunewuproductsumustubeutestedubyutheuFDAubeforeubeingureleasedutoutheupublic.
d. Alludrugsumustuhaveu"warning"ulabels.
ANSWER: a
FEEDBACK: a.uPrescriptionuandunonprescriptionudrugsumustubeushownutoubeueffectiveuasuwelluasusafe.
b. Allulabelsumustubeuaccurateuandumustuincludeuaulistinguofualluactiveuanduinactiveu
ingredients.uTryuagain.
c. TheuFDAumustuapproveuallunewuproductsubeforeutheyuareureleasedutoutheupublic.uTryu
again.
d. Warningulabelsumustubeupresentuonucertainupreparations.uTryuagain.
POINTS: 1
QUESTIONuTYPE:u MultipleuChoice
HASuVARIABLES:u False
DATEuCREATED: 11/26/2017u8:26uPM
DATEuMODIFIED:u 11/26/2017u8:30uPM
5. Anuolderuadultuclientu isureluctantutoutakeuanyuprescribedumedicationsuanduquestionsutheunurseuaboututhe
Pageu2
, Name: Class: Date:u
Chapteru1uConsumeruSafetyuanduDruguRegulations
productionuprocessuandusafetyuofuherumedications.uHowushouldutheunurseurespond?
a. FederalulawsurequireualludrugsumarketeduinutheuUniteduStatesutoumeetutheuminimalustandardsuofust
rength,upurity,uanduquality.
b. MostumedicationsuareumadeuoutsideutheuUniteduStates.
c. Pharmaceuticalucompaniesufollowutheiruownuguidelines.
d. Insuranceucarriersusetutheuparametersuforudrugumanufacturing.
ANSWER: a
FEEDBACK:
a.uFederalulawsurequireualludrugsumarketeduinutheuUniteduStatesutoumeetutheumi
nimalustandardsuofu strength,upurity,uanduquality.
b. MedicationsumadeuoutuofutheuUniteduStatesuoruillegallyuareunotucontrolledubyudrugu
standards.uTryuagain.
c. Althoughupharmaceuticalucompaniesudouhaveuguidelines,utheufinaluauthorizationuforu
releaseduproductsuisuthroughutheuFDA.uTryuagain.
d. Insuranceucarriersudounotumanufactureumedications.uTryuagain.
POINTS: 1
QUESTIONuTYPE:u MultipleuChoice
HASuVARIABLES:u False
DATEuCREATED: 11/26/2017u8:33uPM
DATEuMODIFIED:u 11/26/2017u8:35uPM
6. Theunurseuinutheulocaludrugupreventionuclinicuisuaskedubyuauclientuaboututheurelativeudangeruofuvariousudrugs.uS
heuexplainsuthatutheuDruguEnforcementuAdministrationu(DEA)uclassifiesudrugsuthatucanubeuabuseduoruhaveuaddic
tiveupropertiesuintoucategoriesuoruschedules.uWhichuofutheufollowinguareufactorsuthatuareuconsidereduwhenuclassif
yingutheuscheduleuofuauparticularudrug?u(SELECTu ALLuTHATuAPPLY.)
a. theupotentialucostutouproduceutheudrug
b. theumedicaluvalueuofutheudrug
c. theuharmfulnessuofutheudrug
d. theupotentialuforuabuseuoruaddiction
e. theupopularityuofutheumedication
ANSWER: b,uc,ud
FEEDBACK: a.uTheucostutouproduceuaudruguisunotuaucategoryuclassifiedubyutheuDEA.
b. TheuDruguEnforcementuAdministrationudividesucontrolledusubstancesuintoufiveulevelsuoru
schedulesuaccordingutoutheirumedicaluvalue.
c. HarmfulnessuofuaudruguisuoneucriterionuthatutheuDEAuusesutoucategorizeuaudrug.
d. PotentialuforuabuseuisuoneucriterionuthatutheuDEAuusesutoucategorizeudrugs.
e. Theupopularityuofutheumedicationuisunotuconsidered.uTheuDEAudoesutakeuintouconsiderat
ionusocietaluproblemsuwithumedicationuanduthatumayucauseutheumedicationutoubeumovedu
fromuoneuscheduleutouanother.
POINTS: 1
QUESTIONuTYPE:u MultipleuResponse
HASuVARIABLES:u False
DATEuCREATED: 11/28/2017u2:43uAM
DATEuMODIFIED:u 11/28/2017u2:45uAM
Pageu3
Chapteru1uConsumeruSafetyuanduDruguRegulations
1. Auclientucallsuheruprimaryucareuproviderurequestinguauprescriptionuforuanuantidepressantumedication.uSheutellsut
heunurseuthatusheuisuseverelyudepresseduanduwouldulikeutheuprescriptionucalleduinutouherulocalupharmacy.uHowusho
uldutheunurseurespond?
a. Theunurseuencouragesutheuclientutouseeuaupsychiatricuprofessionaluforuanuevaluationutouobtainutheup
rescription.
b. Theunurseutellsutheuclientutouaskutheupharmacistutourecommenduanuover-the-counteruantidepressant.
c. Theunurseucanuofferutouwriteutheuclientuauprescriptionuifuitu isuaurefill.
d. Theunurseuoffersutougiveutheuclientuaufewusamplesutouuseuuntiluherunextuappointment.
ANSWER: a
FEEDBACK:
a.uTheuclientushouldubeuencouragedutouseekuaupsychiatricuprofessionaluevaluationutouo
btainutheuprescription.
b. Antidepressantsuareunotusolduasuover-the-
counterumedications;uauprescriptionuisurequired.uTryuagain.
c. Theunurseucannotuwriteuauprescriptionuwithoutuevaluatingutheuclient.uTryuagain.
d. Samplesuareunotugivenuoututouauclientuwhouhasunotubeenuevaluatedubyuaupractitioner.uTryu
again.
POINTS: 1
QUESTIONuTYPE:u MultipleuChoice
HASuVARIABLES:u False
DATEuCREATED: 11/26/2017u8:16uPM
DATEuMODIFIED:u 11/26/2017u8:32uPM
2. Auclientuvisitsuheruhealthucareuprovideruforuheruannualuphysical.uSheuquestionsutheunurseuregardingutheuuseuofua
nuherbalusupplementuthatusheusawuadvertiseduonutelevisionuforuweightuloss.uWhatuinformationucanutheunurseushar
euwithuheruclient?
a. TheuproductionuofuherbalumedicinesuisunoturegulatedubyutheuFDA.
b. UnderutheuDietaryuSupplementu HealthuanduEducationuActuofu1994u(DSHEA),utheuFDAuisuresponsibleuf
oruensuringuthatuaudietaryusupplementu isusafeubeforeu ituisumarketed.
c. HerbalumedicinesuareutestedubyutheuFDAutoudetermineuifutheyuhaveuinteractionsuwithuprescribedu
medications.
d. Herbalumedicines,uwhileunotuapprovedubyutheuFDA,uareuconsidereduharmless.
ANSWER: a
FEEDBACK: a.uTheuproductionuofuherbalumedicinesuisunoturegulatedubyutheuFDA.
b. UnderutheuDietaryuSupplementuHealthuanduEducationuActuofu1994u(DSHEA),utheudietaryu
manufactureruisuresponsibleuforuensuringuthatuaudietaryusupplementuisusafeubeforeuituisu
marketed.uTryuagain.
c. TheuFDAudoesunotutestusupplements.uTryuagain.
d. Thereuareudocumenteduinteractionsuwithuspecificuherbalusupplementsuanduprescribedu
medications.uTryuagain.
POINTS: 1
QUESTIONuTYPE:u MultipleuChoice
HASuVARIABLES:u False
DATEuCREATED: 11/26/2017u8:22uPM
DATEuMODIFIED:u 11/26/2017u8:32uPM
Pageu1
,Name: Class: Date:u
Chapteru1uConsumeruSafetyuanduDruguRegulations
3. Uponuleavingutheuexamuroom,uauclientutellsutheunurseuthatusheuisuconfuseduregardinguheruprescription.uSheuasksuth
eunurseuifuaucheaper,ugenericudruguwillubeuweakeruthanuherucurrentuprescription.uHowushouldutheunurseurespond?
a. Drugustandardsuassureuconsumersuthatutheusameudrugumustubeuofuuniformustrength,uquality,uandupurity.
b. Theuprescribedumedicationuisuofubetteruqualityubutuwillucostumore.
c. Theuinsuranceucompaniesumandateuthereuareudifferentustrengthsubetweenugenericuandubrandunameup
rescriptions.
d. Everyudruguhasuaudifferentuchemicalucompositionuthatucannotubeuduplicated.
ANSWER: a
FEEDBACK:
a.uDrugustandardsuassureuconsumersuthatutheusameudrugumustubeuofuuniformustre
ngth,uquality,uandupurity.
b. Genericuandutradeudrugsuareutheusameumedication.uGenericuisutheunameuthatuisuassignedu
touaunewudrug.uTheutradeunameuisutheunameutheupharmaceuticalucompanyuassignsutouthatu
drugutouhaveuexclusiveurightsutoumarketuit.uTryuagain.
c. Insuranceucompaniesuhaveunoucontroluoverutheuproductionuofumedication.uTryuagain.
d. Theulawsuregulatingudrugsustateuthatuconsumersucanubeuassureduthatuallupreparationsu
withutheusameunameuhaveutheusameuuniformu strength,uquality,uandupurity.uTryuagain.
POINTS: 1
QUESTIONuTYPE:u MultipleuChoice
HASuVARIABLES:u False
DATEuCREATED: 11/26/2017u8:23uPM
DATEuMODIFIED:u 11/26/2017u8:31uPM
4. TheuFDA,uunderutheudirectionuofutheuDepartmentuofuHealthuanduHumanuServices,u mandatesuwhichuofutheuf
ollowing?
a. Prescriptionuandunonprescriptionudrugsumustubeushownutoubeueffectiveuasuwelluasusafe.
b. Allulabelsumustuincludeuaulistinguofuactiveuingredients;usomeulabelsurequireuaulistinguofuinactiveuin
gredientsuasuwell.
c. AllunewuproductsumustubeutestedubyutheuFDAubeforeubeingureleasedutoutheupublic.
d. Alludrugsumustuhaveu"warning"ulabels.
ANSWER: a
FEEDBACK: a.uPrescriptionuandunonprescriptionudrugsumustubeushownutoubeueffectiveuasuwelluasusafe.
b. Allulabelsumustubeuaccurateuandumustuincludeuaulistinguofualluactiveuanduinactiveu
ingredients.uTryuagain.
c. TheuFDAumustuapproveuallunewuproductsubeforeutheyuareureleasedutoutheupublic.uTryu
again.
d. Warningulabelsumustubeupresentuonucertainupreparations.uTryuagain.
POINTS: 1
QUESTIONuTYPE:u MultipleuChoice
HASuVARIABLES:u False
DATEuCREATED: 11/26/2017u8:26uPM
DATEuMODIFIED:u 11/26/2017u8:30uPM
5. Anuolderuadultuclientu isureluctantutoutakeuanyuprescribedumedicationsuanduquestionsutheunurseuaboututhe
Pageu2
, Name: Class: Date:u
Chapteru1uConsumeruSafetyuanduDruguRegulations
productionuprocessuandusafetyuofuherumedications.uHowushouldutheunurseurespond?
a. FederalulawsurequireualludrugsumarketeduinutheuUniteduStatesutoumeetutheuminimalustandardsuofust
rength,upurity,uanduquality.
b. MostumedicationsuareumadeuoutsideutheuUniteduStates.
c. Pharmaceuticalucompaniesufollowutheiruownuguidelines.
d. Insuranceucarriersusetutheuparametersuforudrugumanufacturing.
ANSWER: a
FEEDBACK:
a.uFederalulawsurequireualludrugsumarketeduinutheuUniteduStatesutoumeetutheumi
nimalustandardsuofu strength,upurity,uanduquality.
b. MedicationsumadeuoutuofutheuUniteduStatesuoruillegallyuareunotucontrolledubyudrugu
standards.uTryuagain.
c. Althoughupharmaceuticalucompaniesudouhaveuguidelines,utheufinaluauthorizationuforu
releaseduproductsuisuthroughutheuFDA.uTryuagain.
d. Insuranceucarriersudounotumanufactureumedications.uTryuagain.
POINTS: 1
QUESTIONuTYPE:u MultipleuChoice
HASuVARIABLES:u False
DATEuCREATED: 11/26/2017u8:33uPM
DATEuMODIFIED:u 11/26/2017u8:35uPM
6. Theunurseuinutheulocaludrugupreventionuclinicuisuaskedubyuauclientuaboututheurelativeudangeruofuvariousudrugs.uS
heuexplainsuthatutheuDruguEnforcementuAdministrationu(DEA)uclassifiesudrugsuthatucanubeuabuseduoruhaveuaddic
tiveupropertiesuintoucategoriesuoruschedules.uWhichuofutheufollowinguareufactorsuthatuareuconsidereduwhenuclassif
yingutheuscheduleuofuauparticularudrug?u(SELECTu ALLuTHATuAPPLY.)
a. theupotentialucostutouproduceutheudrug
b. theumedicaluvalueuofutheudrug
c. theuharmfulnessuofutheudrug
d. theupotentialuforuabuseuoruaddiction
e. theupopularityuofutheumedication
ANSWER: b,uc,ud
FEEDBACK: a.uTheucostutouproduceuaudruguisunotuaucategoryuclassifiedubyutheuDEA.
b. TheuDruguEnforcementuAdministrationudividesucontrolledusubstancesuintoufiveulevelsuoru
schedulesuaccordingutoutheirumedicaluvalue.
c. HarmfulnessuofuaudruguisuoneucriterionuthatutheuDEAuusesutoucategorizeuaudrug.
d. PotentialuforuabuseuisuoneucriterionuthatutheuDEAuusesutoucategorizeudrugs.
e. Theupopularityuofutheumedicationuisunotuconsidered.uTheuDEAudoesutakeuintouconsiderat
ionusocietaluproblemsuwithumedicationuanduthatumayucauseutheumedicationutoubeumovedu
fromuoneuscheduleutouanother.
POINTS: 1
QUESTIONuTYPE:u MultipleuResponse
HASuVARIABLES:u False
DATEuCREATED: 11/28/2017u2:43uAM
DATEuMODIFIED:u 11/28/2017u2:45uAM
Pageu3
